glp 1 drugs for pcos GLP-1s and PMOS: PCOS, Insulin Resistance, and Weight Loss GLP-1 Medications for PCOS: Weight

Others have had similar experiences and are also standing up against Eli Lilly in individual and group lawsuits

A common mechanism is enzyme inhibition or induction, particularly involving cytochrome P450 (CYP) enzymes

For other individuals, however, the benefits of improved glycemic control, weight loss, and cardiovascular risk reduction may outweigh theoretical concerns

PMID: Summary Keywords biologic therapy, early psoriatic arthritis, GLP-1 receptor agonists, inflammation, metabolic syndrome, psoriasis Citation Ciancio G, Maranini B, Sandri G, Amati G, Bortoluzzi A, Silvagni E, Govoni M and Giuggioli D (2026) Glucagon-like peptide-1 receptor agonists in psoriasis and psoriatic arthritis: emerging evidence and future research opportunities

Bourron O, Ciangura C, Bouillot JL, Massias L, Poitou C, Oppert JM

Mojtahed A, Kelly J, Herlihy AH, et al